Kintara Therapeutics Inc
NASDAQ:KTRA
Income Statement
Earnings Waterfall
Kintara Therapeutics Inc
Income Statement
Kintara Therapeutics Inc
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(8)
|
(8)
|
(8)
|
(7)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(12)
|
(11)
|
(11)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(26)
|
(29)
|
(34)
|
(38)
|
(25)
|
(25)
|
(24)
|
(23)
|
(21)
|
(19)
|
(17)
|
(15)
|
(13)
|
(11)
|
(9)
|
(8)
|
|
| Selling, General & Administrative |
(5)
|
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(9)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
|
| Research & Development |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(20)
|
(22)
|
(25)
|
(28)
|
(14)
|
(16)
|
(15)
|
(15)
|
(15)
|
(13)
|
(11)
|
(9)
|
(8)
|
(6)
|
(5)
|
(3)
|
|
| Operating Income |
(8)
N/A
|
(8)
+2%
|
(8)
-1%
|
(7)
+6%
|
(5)
+34%
|
(5)
+1%
|
(5)
-9%
|
(5)
-5%
|
(6)
-15%
|
(7)
-16%
|
(7)
0%
|
(8)
-5%
|
(8)
-10%
|
(9)
-8%
|
(10)
-16%
|
(12)
-11%
|
(11)
+3%
|
(11)
+6%
|
(9)
+13%
|
(8)
+14%
|
(8)
-6%
|
(8)
+4%
|
(8)
+1%
|
(8)
-4%
|
(8)
+2%
|
(26)
-213%
|
(29)
-14%
|
(34)
-16%
|
(38)
-12%
|
(25)
+35%
|
(25)
-2%
|
(24)
+5%
|
(23)
+5%
|
(21)
+6%
|
(19)
+11%
|
(17)
+11%
|
(15)
+12%
|
(13)
+11%
|
(11)
+19%
|
(9)
+11%
|
(8)
+10%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
20
|
12
|
12
|
13
|
0
|
0
|
(2)
|
(0)
|
(3)
|
(2)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
12
N/A
|
4
-68%
|
4
+6%
|
5
+26%
|
(4)
N/A
|
(5)
-6%
|
(7)
-44%
|
(6)
+14%
|
(9)
-55%
|
(10)
-8%
|
(8)
+14%
|
(9)
-9%
|
(8)
+10%
|
(8)
-5%
|
(10)
-22%
|
(11)
-10%
|
(11)
+2%
|
(10)
+6%
|
(9)
+13%
|
(8)
+14%
|
(8)
-3%
|
(8)
+5%
|
(8)
+1%
|
(8)
-4%
|
(9)
-16%
|
(27)
-196%
|
(31)
-14%
|
(35)
-15%
|
(38)
-8%
|
(25)
+35%
|
(25)
-2%
|
(24)
+5%
|
(23)
+5%
|
(21)
+6%
|
(19)
+11%
|
(17)
+11%
|
(15)
+13%
|
(13)
+11%
|
(11)
+19%
|
(9)
+12%
|
(8)
+11%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
12
|
4
|
4
|
5
|
(4)
|
(5)
|
(7)
|
(6)
|
(9)
|
(10)
|
(8)
|
(9)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(10)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(27)
|
(31)
|
(35)
|
(38)
|
(25)
|
(25)
|
(24)
|
(23)
|
(21)
|
(19)
|
(17)
|
(15)
|
(13)
|
(11)
|
(9)
|
(8)
|
|
| Net Income (Common) |
12
N/A
|
4
-68%
|
4
+6%
|
5
+26%
|
(4)
N/A
|
(5)
-6%
|
(7)
-44%
|
(6)
+14%
|
(9)
-59%
|
(10)
-11%
|
(9)
+12%
|
(10)
-11%
|
(9)
+10%
|
(9)
-1%
|
(11)
-19%
|
(12)
-8%
|
(11)
+3%
|
(11)
+6%
|
(9)
+13%
|
(8)
+14%
|
(8)
-2%
|
(8)
+5%
|
(8)
+1%
|
(8)
-4%
|
(9)
-16%
|
(30)
-231%
|
(34)
-12%
|
(39)
-14%
|
(42)
-8%
|
(27)
+34%
|
(28)
-2%
|
(26)
+5%
|
(25)
+5%
|
(22)
+14%
|
(19)
+11%
|
(17)
+11%
|
(15)
+12%
|
(13)
+12%
|
(11)
+18%
|
(10)
+12%
|
(9)
+11%
|
|
| EPS (Diluted) |
245.6
N/A
|
198.5
-19%
|
210.99
+6%
|
266.5
+26%
|
-217.49
N/A
|
-231.52
-6%
|
-332.99
-44%
|
-285.5
+14%
|
-455
-59%
|
-504
-11%
|
-445.5
+12%
|
-492.5
-11%
|
-443.49
+10%
|
-299.33
+33%
|
-214.4
+28%
|
-232.4
-8%
|
-282.75
-22%
|
-212.8
+25%
|
-185
+13%
|
-159.19
+14%
|
-162.6
-2%
|
-51.46
+68%
|
-33.17
+36%
|
-34.34
-4%
|
-43.47
-27%
|
-88.94
-105%
|
-67.84
+24%
|
-65.42
+4%
|
-79.8
-22%
|
-39.46
+51%
|
-28.56
+28%
|
-26.96
+6%
|
-25.9
+4%
|
-14.84
+43%
|
-11.72
+21%
|
-10.2
+13%
|
-9.27
+9%
|
-7.68
+17%
|
-2.48
+68%
|
-0.21
+92%
|
-0.32
-52%
|
|